Bankwell Financial Group, Inc.
For the period ended Dec 31, 2025. Filed Mar 4, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 4, 2026
BWFG$70.73+0.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets as of December 31, 202 and
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| ASSETS | ||
| Cash and due from banks | $214,567 | $293,552 |
| Federal funds sold | 10,354 | 13,972 |
| Cash and cash equivalents | 224,921 | $307,524 |
| Investment securities | ||
| Marketable equity securities, at fair value | 2,248 | 2,118 |
| Available for sale investment securities, at fair value | 160,409 | 107,428 |
| Held to maturity investment securities, at amortized cost (fair values of $31,045 and $36,691 at December 31, 2025 and 2024, respectively) | 29,465 | 36,553 |
| Total investment securities | 192,122 | 146,099 |
| Loans receivable (net of ACL-Loans of $30,705 and $29,007 at December 31, 2025 and 2024, respectively) | 2,804,441 | 2,672,959 |
| Other real estate owned | — | 8,299 |
| Accrued interest receivable | 16,143 | 14,535 |
| Federal Home Loan Bank stock, at cost | 6,207 | 5,655 |
| Premises and equipment, net | 21,582 | 23,856 |
| Bank-owned life insurance | 54,207 | 52,791 |
| Goodwill | 2,589 | 2,589 |
| Deferred income taxes, net | 11,356 | 9,742 |
| Other assets | 26,291 | 24,427 |
| Total assets | $3,359,859 | $3,268,476 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||
| Liabilities | ||
| Deposits | ||
| Noninterest bearing deposits | $403,652 | $321,875 |
| Interest bearing deposits | 2,425,829 | 2,465,695 |
| Total deposits | 2,829,481 | 2,787,570 |
| Advances from the Federal Home Loan Bank | 110,000 | 90,000 |
| Subordinated debentures (face value of $70,000 and $70,000 at December 31, 2025 and 2024, respectively, less unamortized debt issuance costs of $303 and $549 at December 31, 2025 and 2024, respectively) | 69,697 | 69,451 |
| Accrued expenses and other liabilities | 49,192 | 50,935 |
| Total liabilities | 3,058,370 | 2,997,956 |
| Commitments and contingencies (Note 12) | ||
| Shareholders’ equity | ||
| Common stock, no par value; 10,000,000 shares authorized, 7,899,943 and 7,859,873 shares issued and outstanding at December 31, 2025 and 2024, respectively | 120,118 | 119,108 |
| Retained earnings | 181,587 | 152,656 |
| Accumulated other comprehensive loss | (216) | (1,244) |
| Total shareholders’ equity | 301,489 | 270,520 |
| Total liabilities and shareholders’ equity | $3,359,859 | $3,268,476 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.